Reconstitute in sterile 18MOhm/cm H2O at not less than 100 µg/ml, which can then be further diluted to other aqueous solutions.
Lanreotide is a a synthetic cyclic octapeptide used as a drug in the management of acromegaly and symptoms caused by neuroendocrine tumors, most notably carcinoid syndrome. Lanreotide is a synthetic analogue of somatostatin, a naturally occurring inhibitory hormone which blocks the release of several other hormones, including growth hormone, thyroid-stimulating hormone (TSH), insulin and glucagon. Lanreotide binds to the same receptors as somatostatin, although with higher affinity to peripheral receptors, and has similar activity. However, while somatostatin is quickly broken down in the body (within minutes), lanreotide has a much longer half-life, and produces far more prolonged effects.
Lanreotide peptide (ab73337) 使用論文
has not yet been referenced specifically in any publications.